ALPACA: Promising results for dose de-escalated regimen of gemcitabine/nab-paclitaxel in metastatic PDAC Presented ByProf. Frank Kullmann, Hospital Weiden, Germany TrialPhase 2, ALPACA (AIO-PAK-0114) ConferenceASCO GI 2024 13 February, 2024 12:48